Physician profile
Jeffrey P Edelstein
NPI 1699749150
$994.36
in general payments reported to CMS, 2019-2025
10 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Plastic Surgery Within The Head and Neck provider received nationally (typical 2025 total: $300).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.31 · 2020: $142 · 2021: $377 · 2022: $192 · 2023: $44.32 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $258.39 | 2019-2023 | Tepezza |
| Alcon Vision LLC | $147.42 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $119.24 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $112.66 | 2025 | Miebo, Xiidra |
| Glaukos Corporation | $107.51 | 2021 | |
| Dompe US, INC. | $95.30 | 2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $73.63 | 2022 | |
| Ocular Therapeutix, INC. | $37.30 | 2022 | |
| Boston Scientific Corporation | $23.51 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Edelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.